These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23522637)

  • 1. Acid aspiration provokes the pneumonia caused by multidrug-resistant Acinetobacter baumannii in BALB/c mice.
    Chiang SR; Tang HJ; Chen CH; Chen CC; Lee WY; Chang PC; Chiu YH; Chuang YC
    Int J Infect Dis; 2013 Jun; 17(6):e454-60. PubMed ID: 23522637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of intratracheal colistimethate sodium, imipenem, and meropenem in BALB/c mice with carbapenem-resistant Acinetobacter baumannii pneumonia.
    Tang HJ; Chuang YC; Ko WC; Chen CC; Shieh JM; Chen CH; Lee NY; Chiang SR
    Int J Infect Dis; 2012 Jan; 16(1):e34-40. PubMed ID: 22088863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratracheal colistin sulfate for BALB/c mice with early pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
    Chiang SR; Chuang YC; Tang HJ; Chen CC; Chen CH; Lee NY; Chou CH; Ko WC
    Crit Care Med; 2009 Sep; 37(9):2590-5. PubMed ID: 19623044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse pneumonia model by Acinetobacter baumannii multidrug resistant strains: Comparison between intranasal inoculation, intratracheal instillation and oropharyngeal aspiration techniques.
    Bergamini G; Perico ME; Di Palma S; Sabatini D; Andreetta F; Defazio R; Felici A; Ferrari L
    PLoS One; 2021; 16(12):e0260627. PubMed ID: 34855837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Establishment of Acinetobacter baumannii-induced pneumonia model in mice].
    Zhang Y; Zhou X; Zhang H; Huan C; Ye Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Oct; 33(10):1392-1397. PubMed ID: 29169425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of tigecycline/colistin combination in a pneumonia model caused by extensively drug-resistant Acinetobacter baumannii.
    Mutlu Yilmaz E; Sunbul M; Aksoy A; Yilmaz H; Guney AK; Guvenc T
    Int J Antimicrob Agents; 2012 Oct; 40(4):332-6. PubMed ID: 22831842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic effect of phages on extensively drug-resistant Acinetobacter baumannii-induced sepsis in mice].
    Deng LY; Yang ZC; Gong YL; Huang GT; Yin SP; Jiang B; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):523-8. PubMed ID: 27647067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A lethal pneumonia model of Acinetobacter baumannii: an investigation in immunocompetent mice.
    Zeng X; Gu H; Cheng Y; Jia KR; Liu D; Yuan Y; Chen ZF; Peng LS; Zou QM; Shi Y
    Clin Microbiol Infect; 2019 Apr; 25(4):516.e1-516.e4. PubMed ID: 30583061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo activity of meropenem and sulbactam against a multidrug-resistant Acinetobacter baumannii strain.
    Ko WC; Lee HC; Chiang SR; Yan JJ; Wu JJ; Lu CL; Chuang YC
    J Antimicrob Chemother; 2004 Feb; 53(2):393-5. PubMed ID: 14729739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acute-phase response and serum amyloid A inhibit the inflammatory response to Acinetobacter baumannii Pneumonia.
    Renckens R; Roelofs JJ; Knapp S; de Vos AF; Florquin S; van der Poll T
    J Infect Dis; 2006 Jan; 193(2):187-95. PubMed ID: 16362882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchoalveolar interleukin-1 beta: a marker of bacterial burden in mechanically ventilated patients with community-acquired pneumonia.
    Wu CL; Lee YL; Chang KM; Chang GC; King SL; Chiang CD; Niederman MS
    Crit Care Med; 2003 Mar; 31(3):812-7. PubMed ID: 12626989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cationic amphiphilic alpha-helical peptides for the treatment of carbapenem-resistant Acinetobacter baumannii infection.
    Huang Y; Wiradharma N; Xu K; Ji Z; Bi S; Li L; Yang YY; Fan W
    Biomaterials; 2012 Dec; 33(34):8841-7. PubMed ID: 22925814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam.
    Pachón-Ibáñez ME; Fernández-Cuenca F; Docobo-Pérez F; Pachón J; Pascual A
    J Antimicrob Chemother; 2006 Sep; 58(3):689-92. PubMed ID: 16870647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azithromycin attenuates lung inflammation in a mouse model of ventilator-associated pneumonia by multidrug-resistant Acinetobacter baumannii.
    Yamada K; Yanagihara K; Kaku N; Harada Y; Migiyama Y; Nagaoka K; Morinaga Y; Nakamura S; Imamura Y; Miyazaki T; Izumikawa K; Kakeya H; Hasegawa H; Mikamo H; Kohno S
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3883-8. PubMed ID: 23733468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose ampicillin-sulbactam as an alternative treatment of late-onset VAP from multidrug-resistant Acinetobacter baumannii.
    Betrosian AP; Frantzeskaki F; Xanthaki A; Georgiadis G
    Scand J Infect Dis; 2007; 39(1):38-43. PubMed ID: 17366011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model.
    Song JY; Cheong HJ; Lee J; Sung AK; Kim WJ
    Int J Antimicrob Agents; 2009 Jan; 33(1):33-9. PubMed ID: 18835761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug-resistant Acinetobacter baumannii in ventilator-associated pneumonia at a medical center in southern Taiwan.
    Mai MH; Tsai HC; Lee SS; Wang YH; Chen YS; Wann SR; Liu YC
    J Microbiol Immunol Infect; 2007 Oct; 40(5):401-5. PubMed ID: 17932599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.
    Montero A; Ariza J; Corbella X; Doménech A; Cabellos C; Ayats J; Tubau F; Borraz C; Gudiol F
    J Antimicrob Chemother; 2004 Dec; 54(6):1085-91. PubMed ID: 15546972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colistin offers prolonged survival in experimental infection by multidrug-resistant Acinetobacter baumannii: the significance of co-administration of rifampicin.
    Pantopoulou A; Giamarellos-Bourboulis EJ; Raftogannis M; Tsaganos T; Dontas I; Koutoukas P; Baziaka F; Giamarellou H; Perrea D
    Int J Antimicrob Agents; 2007 Jan; 29(1):51-5. PubMed ID: 17189095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective Effect of a Synbiotic against Multidrug-Resistant Acinetobacter baumannii in a Murine Infection Model.
    Asahara T; Takahashi A; Yuki N; Kaji R; Takahashi T; Nomoto K
    Antimicrob Agents Chemother; 2016 May; 60(5):3041-50. PubMed ID: 26953197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.